世界の細菌性肺炎治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Bacterial Pneumonia Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0692 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、細菌性肺炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、ワクチン）、用途別市場規模（病院薬局、小売薬局、通信販売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・細菌性肺炎治療の市場動向 ・企業の競争状況、市場シェア ・細菌性肺炎治療の種類別市場規模（抗生物質、ワクチン） ・細菌性肺炎治療の用途別市場規模（病院薬局、小売薬局、通信販売薬局） ・細菌性肺炎治療の北米市場規模2016-2027（アメリカ、カナダ） ・細菌性肺炎治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・細菌性肺炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・細菌性肺炎治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・細菌性肺炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca、Nabriva Therapeutics、SetLance、Merck、Daiichi Sankyo Company、GlaxoSmithKline、Pfizer、Sanofi Pasteur） ・結論

Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year.
Increase in bacterial resistance of streptococcus bacteria, HIV associated pneumonia, rise in prevalence of pneumonia and government initiatives are major factors driving the growth of bacterial pneumonia therapeutics market over the forecast period. According to national statistics UK, in 2013, 5% of deaths in England and Wales are associated due to pneumonia and influenza. Lack of new drugs and improper diagnosis of pneumonia conditions are hindering the growth of this market over the forecast period.

Market Analysis and Insights: Global Bacterial Pneumonia Therapeutics Market
The global Bacterial Pneumonia Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bacterial Pneumonia Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bacterial Pneumonia Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bacterial Pneumonia Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bacterial Pneumonia Therapeutics market.

Global Bacterial Pneumonia Therapeutics Scope and Market Size
Bacterial Pneumonia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bacterial Pneumonia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antibiotics
Vaccines

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Mail Order Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Nabriva Therapeutics
SetLance
Merck
Daiichi Sankyo Company
GlaxoSmithKline
Pfizer
Sanofi Pasteur

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bacterial Pneumonia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotics
1.2.3 Vaccines
1.3 Market by Application
1.3.1 Global Bacterial Pneumonia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Mail Order Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bacterial Pneumonia Therapeutics Market Perspective (2016-2027)
2.2 Bacterial Pneumonia Therapeutics Growth Trends by Regions
2.2.1 Bacterial Pneumonia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bacterial Pneumonia Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Bacterial Pneumonia Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Bacterial Pneumonia Therapeutics Industry Dynamic
2.3.1 Bacterial Pneumonia Therapeutics Market Trends
2.3.2 Bacterial Pneumonia Therapeutics Market Drivers
2.3.3 Bacterial Pneumonia Therapeutics Market Challenges
2.3.4 Bacterial Pneumonia Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bacterial Pneumonia Therapeutics Players by Revenue
3.1.1 Global Top Bacterial Pneumonia Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Bacterial Pneumonia Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Bacterial Pneumonia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bacterial Pneumonia Therapeutics Revenue
3.4 Global Bacterial Pneumonia Therapeutics Market Concentration Ratio
3.4.1 Global Bacterial Pneumonia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bacterial Pneumonia Therapeutics Revenue in 2020
3.5 Bacterial Pneumonia Therapeutics Key Players Head office and Area Served
3.6 Key Players Bacterial Pneumonia Therapeutics Product Solution and Service
3.7 Date of Enter into Bacterial Pneumonia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bacterial Pneumonia Therapeutics Breakdown Data by Type
4.1 Global Bacterial Pneumonia Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Bacterial Pneumonia Therapeutics Forecasted Market Size by Type (2022-2027)

5 Bacterial Pneumonia Therapeutics Breakdown Data by Application
5.1 Global Bacterial Pneumonia Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Bacterial Pneumonia Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bacterial Pneumonia Therapeutics Market Size (2016-2027)
6.2 North America Bacterial Pneumonia Therapeutics Market Size by Type
6.2.1 North America Bacterial Pneumonia Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Bacterial Pneumonia Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Bacterial Pneumonia Therapeutics Market Size by Type (2016-2027)
6.3 North America Bacterial Pneumonia Therapeutics Market Size by Application
6.3.1 North America Bacterial Pneumonia Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Bacterial Pneumonia Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Bacterial Pneumonia Therapeutics Market Size by Application (2016-2027)
6.4 North America Bacterial Pneumonia Therapeutics Market Size by Country
6.4.1 North America Bacterial Pneumonia Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Bacterial Pneumonia Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Bacterial Pneumonia Therapeutics Market Size (2016-2027)
7.2 Europe Bacterial Pneumonia Therapeutics Market Size by Type
7.2.1 Europe Bacterial Pneumonia Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Bacterial Pneumonia Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Bacterial Pneumonia Therapeutics Market Size by Type (2016-2027)
7.3 Europe Bacterial Pneumonia Therapeutics Market Size by Application
7.3.1 Europe Bacterial Pneumonia Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Bacterial Pneumonia Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Bacterial Pneumonia Therapeutics Market Size by Application (2016-2027)
7.4 Europe Bacterial Pneumonia Therapeutics Market Size by Country
7.4.1 Europe Bacterial Pneumonia Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Bacterial Pneumonia Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bacterial Pneumonia Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Bacterial Pneumonia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Bacterial Pneumonia Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bacterial Pneumonia Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bacterial Pneumonia Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Bacterial Pneumonia Therapeutics Market Size by Application
8.3.1 Asia-Pacific Bacterial Pneumonia Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bacterial Pneumonia Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bacterial Pneumonia Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Bacterial Pneumonia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Bacterial Pneumonia Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bacterial Pneumonia Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bacterial Pneumonia Therapeutics Market Size (2016-2027)
9.2 Latin America Bacterial Pneumonia Therapeutics Market Size by Type
9.2.1 Latin America Bacterial Pneumonia Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Bacterial Pneumonia Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Bacterial Pneumonia Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Bacterial Pneumonia Therapeutics Market Size by Application
9.3.1 Latin America Bacterial Pneumonia Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Bacterial Pneumonia Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Bacterial Pneumonia Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Bacterial Pneumonia Therapeutics Market Size by Country
9.4.1 Latin America Bacterial Pneumonia Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Bacterial Pneumonia Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bacterial Pneumonia Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Bacterial Pneumonia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Bacterial Pneumonia Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bacterial Pneumonia Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bacterial Pneumonia Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Bacterial Pneumonia Therapeutics Market Size by Application
10.3.1 Middle East & Africa Bacterial Pneumonia Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bacterial Pneumonia Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bacterial Pneumonia Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Bacterial Pneumonia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Bacterial Pneumonia Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bacterial Pneumonia Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Bacterial Pneumonia Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Bacterial Pneumonia Therapeutics Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Nabriva Therapeutics
11.2.1 Nabriva Therapeutics Company Details
11.2.2 Nabriva Therapeutics Business Overview
11.2.3 Nabriva Therapeutics Bacterial Pneumonia Therapeutics Introduction
11.2.4 Nabriva Therapeutics Revenue in Bacterial Pneumonia Therapeutics Business (2016-2021)
11.2.5 Nabriva Therapeutics Recent Development
11.3 SetLance
11.3.1 SetLance Company Details
11.3.2 SetLance Business Overview
11.3.3 SetLance Bacterial Pneumonia Therapeutics Introduction
11.3.4 SetLance Revenue in Bacterial Pneumonia Therapeutics Business (2016-2021)
11.3.5 SetLance Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Bacterial Pneumonia Therapeutics Introduction
11.4.4 Merck Revenue in Bacterial Pneumonia Therapeutics Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Daiichi Sankyo Company
11.5.1 Daiichi Sankyo Company Company Details
11.5.2 Daiichi Sankyo Company Business Overview
11.5.3 Daiichi Sankyo Company Bacterial Pneumonia Therapeutics Introduction
11.5.4 Daiichi Sankyo Company Revenue in Bacterial Pneumonia Therapeutics Business (2016-2021)
11.5.5 Daiichi Sankyo Company Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Bacterial Pneumonia Therapeutics Introduction
11.6.4 GlaxoSmithKline Revenue in Bacterial Pneumonia Therapeutics Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Bacterial Pneumonia Therapeutics Introduction
11.7.4 Pfizer Revenue in Bacterial Pneumonia Therapeutics Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Sanofi Pasteur
11.8.1 Sanofi Pasteur Company Details
11.8.2 Sanofi Pasteur Business Overview
11.8.3 Sanofi Pasteur Bacterial Pneumonia Therapeutics Introduction
11.8.4 Sanofi Pasteur Revenue in Bacterial Pneumonia Therapeutics Business (2016-2021)
11.8.5 Sanofi Pasteur Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bacterial Pneumonia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotics
Table 3. Key Players of Vaccines
Table 4. Global Bacterial Pneumonia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Bacterial Pneumonia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bacterial Pneumonia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Bacterial Pneumonia Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Bacterial Pneumonia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Bacterial Pneumonia Therapeutics Market Share by Regions (2022-2027)
Table 10. Bacterial Pneumonia Therapeutics Market Trends
Table 11. Bacterial Pneumonia Therapeutics Market Drivers
Table 12. Bacterial Pneumonia Therapeutics Market Challenges
Table 13. Bacterial Pneumonia Therapeutics Market Restraints
Table 14. Global Bacterial Pneumonia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Bacterial Pneumonia Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Bacterial Pneumonia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Pneumonia Therapeutics as of 2020)
Table 17. Ranking of Global Top Bacterial Pneumonia Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Bacterial Pneumonia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Bacterial Pneumonia Therapeutics Product Solution and Service
Table 21. Date of Enter into Bacterial Pneumonia Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Bacterial Pneumonia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Bacterial Pneumonia Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Bacterial Pneumonia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Bacterial Pneumonia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Bacterial Pneumonia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Bacterial Pneumonia Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Bacterial Pneumonia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Bacterial Pneumonia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Bacterial Pneumonia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Bacterial Pneumonia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Bacterial Pneumonia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Bacterial Pneumonia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Bacterial Pneumonia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Bacterial Pneumonia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Bacterial Pneumonia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Bacterial Pneumonia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Bacterial Pneumonia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Bacterial Pneumonia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Bacterial Pneumonia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Bacterial Pneumonia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Bacterial Pneumonia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Bacterial Pneumonia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bacterial Pneumonia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bacterial Pneumonia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bacterial Pneumonia Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Bacterial Pneumonia Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Bacterial Pneumonia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Bacterial Pneumonia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Bacterial Pneumonia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Bacterial Pneumonia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Bacterial Pneumonia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Bacterial Pneumonia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Bacterial Pneumonia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Bacterial Pneumonia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bacterial Pneumonia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bacterial Pneumonia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bacterial Pneumonia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Bacterial Pneumonia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Bacterial Pneumonia Therapeutics Product
Table 64. AstraZeneca Revenue in Bacterial Pneumonia Therapeutics Business (2016-2021) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Nabriva Therapeutics Company Details
Table 67. Nabriva Therapeutics Business Overview
Table 68. Nabriva Therapeutics Bacterial Pneumonia Therapeutics Product
Table 69. Nabriva Therapeutics Revenue in Bacterial Pneumonia Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Nabriva Therapeutics Recent Development
Table 71. SetLance Company Details
Table 72. SetLance Business Overview
Table 73. SetLance Bacterial Pneumonia Therapeutics Product
Table 74. SetLance Revenue in Bacterial Pneumonia Therapeutics Business (2016-2021) & (US$ Million)
Table 75. SetLance Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Bacterial Pneumonia Therapeutics Product
Table 79. Merck Revenue in Bacterial Pneumonia Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Daiichi Sankyo Company Company Details
Table 82. Daiichi Sankyo Company Business Overview
Table 83. Daiichi Sankyo Company Bacterial Pneumonia Therapeutics Product
Table 84. Daiichi Sankyo Company Revenue in Bacterial Pneumonia Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Daiichi Sankyo Company Recent Development
Table 86. GlaxoSmithKline Company Details
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Bacterial Pneumonia Therapeutics Product
Table 89. GlaxoSmithKline Revenue in Bacterial Pneumonia Therapeutics Business (2016-2021) & (US$ Million)
Table 90. GlaxoSmithKline Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Bacterial Pneumonia Therapeutics Product
Table 94. Pfizer Revenue in Bacterial Pneumonia Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Pfizer Recent Development
Table 96. Sanofi Pasteur Company Details
Table 97. Sanofi Pasteur Business Overview
Table 98. Sanofi Pasteur Revenue in Bacterial Pneumonia Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Sanofi Pasteur Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bacterial Pneumonia Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Antibiotics Features
Figure 3. Vaccines Features
Figure 4. Global Bacterial Pneumonia Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Mail Order Pharmacies Case Studies
Figure 8. Bacterial Pneumonia Therapeutics Report Years Considered
Figure 9. Global Bacterial Pneumonia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Bacterial Pneumonia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Bacterial Pneumonia Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Bacterial Pneumonia Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Bacterial Pneumonia Therapeutics Market Share by Players in 2020
Figure 14. Global Top Bacterial Pneumonia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Pneumonia Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Bacterial Pneumonia Therapeutics Revenue in 2020
Figure 16. Global Bacterial Pneumonia Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Bacterial Pneumonia Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Bacterial Pneumonia Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Bacterial Pneumonia Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Bacterial Pneumonia Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Bacterial Pneumonia Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Bacterial Pneumonia Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Bacterial Pneumonia Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Bacterial Pneumonia Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Bacterial Pneumonia Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Bacterial Pneumonia Therapeutics Market Share by Region (2016-2027)
Figure 38. China Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Bacterial Pneumonia Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Bacterial Pneumonia Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Bacterial Pneumonia Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Bacterial Pneumonia Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Bacterial Pneumonia Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Bacterial Pneumonia Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Bacterial Pneumonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AstraZeneca Revenue Growth Rate in Bacterial Pneumonia Therapeutics Business (2016-2021)
Figure 58. Nabriva Therapeutics Revenue Growth Rate in Bacterial Pneumonia Therapeutics Business (2016-2021)
Figure 59. SetLance Revenue Growth Rate in Bacterial Pneumonia Therapeutics Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Bacterial Pneumonia Therapeutics Business (2016-2021)
Figure 61. Daiichi Sankyo Company Revenue Growth Rate in Bacterial Pneumonia Therapeutics Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Bacterial Pneumonia Therapeutics Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Bacterial Pneumonia Therapeutics Business (2016-2021)
Figure 64. Sanofi Pasteur Revenue Growth Rate in Bacterial Pneumonia Therapeutics Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---